PBC Biomed are attending the 33rd Annual Meeting of the European Orthopaedic Research Society (EORS) in Davos, Switzerland this week. Chief Science Officer Dr Gerard Insley will be presenting a poster on behalf of the team – ‘Development of a Prototype Model for Lateral Split-Depressed Tibial Plateau for Bench Testing and Fixation Studies’, written by Gerard M. Insley, Thomas A. Russell, Paul Dorrell, & Antzela Tzagiollari. Poster Sessions: Monday 16th June @ 5pm and Wednesday 18th June @ 5pmRoom Number: Po1 – C2 Aspen FoyerPoster Number: Po1_1.29 Overview: Schatzker Type II tibial plateau fractures—complex and clinically challenging—demand innovative, ethical solutions. This latest study introduces a prototype model, initially developed in a synthetic bone followed by ex vivo sheep tibia, to replicate lateral split-depressed fracture mechanics for bench-testing.This reproducible and ethical model enables robust evaluation of bone adhesives and fixation techniques under physiological load, and represents a step forward in accelerating the development of next-gen orthopaedic treatments. #EORS2025 #postersessions #orthopaedics #bioadhesive #acceleratingmedicalinnovation

📢 Join Us for the OssiVet® Webinar – April 14, 2025! 🦴💻 We’re excited to invite veterinary professionals to our upcoming OssiVet® Educational Webinar on Monday, April 14th, 2025. Discover how OssiVet®, our advanced orthopedic bone bioadhesive, is transforming fracture management and joint stabilization in veterinary surgery. From science to real clinical cases, we’ll cover the benefits and techniques that help improve patient outcomes. ✅ Date: Monday, April 14, 2025 ✅ Time: 16:00-17:00 GMT / 17:00-18:00 CET ✅ Format: Online – FREE Registration Topics Include: 🔹 Science behind OssiVet® 🔹 Application techniques 🔹 Clinical case studies 🔹 Q&A with our experts 📩 Register now by messaging us or emailing [email protected] Don’t miss this opportunity to enhance your orthopedic practice! #OssiVet #VeterinaryOrthopedics #VetSurgery #Webinar #VeterinaryMedicine #Innovation #FractureRepair #PBCBioVet

PBC Biomed attend AAOS 2025 Thank you to the PBC Biomed Clinical Advisory Board for their support at the #AAOS event in San Diego last week! Dr Thomas A. (Toney) Russell MD, Dr John Tracy Watson, Dr Hassan Mir, MD, MBA and Professor Peter Giannoudis did a fantastic job of talking booth visitors through the application of our #breakthrough bio-adhesive OsStic®; as providing an insight on the potential clinical value of the material. Next stop, the 2025 European Society of Tissue Regeneration in Orthopaedics & Traumatology (ESTROT) meeting in May!

Our team are celebrating another successful year at the Orthopaedic Trauma Association meeting, which was held in Montreal, QC last week. Our exciting pipeline of new medical innovations, including VAPS (a cell delivering #osteconductive scaffold), our Minimally Invasive Ankle Fixation Device, as well as our structural Bio-adhesive OsStic®, attracted huge levels of interest on our booth. Recently launched Nerve Repair Solution ‘ReFeel®’ was also a significant point of interest among attendees. In relation to our Education Pathway, the third instalment of the ‘Strengthening the Bond’ series was also well attended, with our panel of surgeon advisors discussing ‘Modern Biomaterial Solutions’ as well as facilitating a hands-on demonstrations of our ‘Breakthrough Biomaterial’ OsStic®.* Thank you to all those who stopped by the booth to speak to our team, and/or attended our symposium. We will see you all next year in Phoenix! #OTA2024 #acceleratingmedicalinnovation #PBCBiomed #biomaterials #orthopaedic #biomaterials #breakthrough *OsStic® is currently in development and not available for human use.

PBC Biomed are ready for action at the Orthopaedic Trauma Association meeting in Montreal! Stop by booth #431 to meet our team and learn more about our new #innovations, powered by our Accelerating Innovation Model ‘AIM’. #acceleratingmedicalinnovation #biomaterials #newinnovations

We are delighted to announce that we will be continuing our ‘Strengthening the Bond’ education series at the Orthopaedic Trauma Association meeting in Montreal this week. Strengthening the Bond: Modern Biomaterials for Fracture Fixation and Bone Regeneration. Our global panel of surgeon advisors will discuss current hashtag#Biomaterials and their challenges, as well as plans for the first human implantation of OsStic®, a hashtag#Breakthrough Bio-Adhesive bone void filler technology. Speaker panel is as below: – Peter Giannoudis – John Tracy Watson – Hassan Mir, MD, MBA – Thomas A. (Toney) Russell MD The session will take place on Friday 23rd October at 12:45pm in room 514ABC. See below for further information – we look forward to seeing you there! #OTA2024 #strengtheningthebond #industrylunchseries #pbcbiomed #acceleratingmedicalinnovation #biomimeticinnovations

In September, PBC Biomed and our client Mochida Pharmaceutical., Ltd. hit a significant milestone in our co-development journey. Together, we launched ReFeel® at the American Society for Surgery of the Hand (ASSH) meeting event in Minneapolis, where we demonstrated the technology publicly for the first time with the help of our surgeon advisors. Thank you to Dr Rashard Dacus, Dr Glenn Gaston and Dr William Jake Weller for stopping by our booth to demonstrate application of ReFeel® using our new training models, as well as their guidance throughout the development process of this exciting new technology. We are thrilled to release this new product in the US for treatment of patients with peripherical nerve discontinuities and management of nerve injuries. #ReFeel® #nerverepairsolution #acceleraratingmedicalinnovation #ASSH24

PBC Biomed are delighted to announce the launch of our client Mochida Pharmaceutical Co., Ltd. innovative new nerve repair product – ReFeel® Nerve Repair Solution. ReFeel® is #biocompatible in nature and uses a proprietary alginate and PGA formula to create a bridge for #nerve #regeneration. The freeze-dried alginate sheet suppresses the migration and proliferation of cells that make up granulation tissue; providing a protected environment which facilitates the natural healing process of the nerve. The PBC Biomed Design & Development, Clinical, Regulatory and Commercial teams have been working alongside Mochida Pharmaceutical Co., Ltd. for the last four years; preparing this technology for commercial release. ReFeel® will officially be launched at the American Society for Surgery of the Hand (ASSH) conference in Minneapolis this week. Visit booth #210 for more information on this exciting new technology! Caution: Prescription use only. Federal law (USA) restricts this device to sale by or on the order of a physician. #acceleraratingmedicalinnovation #ASSH24

Pictured at the #ECVS Congress in Valencia, Spain last week are PBC BioVet Managing Director Henk Offereins, and R&D Engineer Antzela Tzagiollari They are available on Booth #34 to answer your questions on our innovative veterinary solutions! #ECVS2024 #VeterinaryCongress #PBCBioVet #AnimalHealthcare #Innovation #ValenciaSpain #VisitUsBooth34

First image of the team at the World Biomaterials Congress in South Korea is in! Tina Hashemi is also pictured presenting on a ‘Comparative Study on the Corrosion Behaviour of Pure Mg and WE43 Alloy with Novel Dual-Layer CaP Coating for Orthopaedic Applications.’ Congratulations to Tina, Nicholas Dunne and other researchers involved in this project! I-Form, the SFI Research Centre for Advanced Manufacturing #WBC #biomaterials #acceleratingmedicalinnovation #DCU #PBCbiomed #collaborativeresearch